TAYLOR GONZALEZ: Open Payments
NPI 1235971755 · SENOIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 28 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $59 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $67 |
| Novo Nordisk Inc | 3 | $66 |
| PFIZER INC. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $20 |
Products named: ELIQUIS, REXULTI, GEMTESA, OTEZLA, VRAYLAR, Ozempic, LEQVIO, JARDIANCE.
Industry payments across GA — which companies pay providers there.
